MedTrace Logo

Trial Comparing Parenteral Nutrition (PN) Using Eurotubes® vs. 2/3-chamber Bags in Subjects With Solid Tumors Requiring PN (PEKANNUSS)

NCT04105777 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2025-01-06

No results posted yet for this study

Summary

Patients with inoperable metastatic or localized solid tumors who have an indication for parenteral nutrition will be enrolled and receive standard parenteral nutrition according to randomization using either 2/3-chamber bags or Eurotubes®, the latter either with or without reduced glucose. The main goal of the trial is to compare the frequency of self-administered parenteral nutrition at home (autonomy rate).

Conditions

Interventions

DEVICE

Parenteral Nutrition Bag Eurotube

7-,8- or 9-chamber bags for individualized parenteral nutrition compounding.

DEVICE

Parenteral Nutrition 2/3 chamber Bag

Premixed 2/3-chamber bags which are eventually completed with other supplements shortly before administration by infusion into the bag.

Sponsors & Collaborators

  • Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

    lead OTHER

Principal Investigators

  • Thorsten Goetze · KHNW Frankfurt, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-30
Primary Completion
2022-11-23
Completion
2023-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04105777 on ClinicalTrials.gov